# Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

> **NCT00058006** · PHASE2 · COMPLETED · sponsor: **Northwestern University**

## Conditions studied

- Head and Neck Cancer
- Lung Cancer

## Interventions

- **DRUG:** celecoxib
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00058006
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00058006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00058006, "Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00058006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*